HNGE · Hinge Health Inc
Price
Snapshot
50 fields · last close| Market Cap | $7.45B |
| P/E | 67.15 |
| Float | 50.01M |
| Beta | 1.58 |
| Volatility | 39.6% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | High |
| Clavix score | 62 |
| Price | 92.37 |
| Change | +0.00% |
| Prev Close | 92.37 |
| Open | 90.00 |
| Day Low | 89.41 |
| Day High | 93.14 |
| Avg Vol | 2 |
| Avg $ Vol | $187.5M |
| 52W High | 95.57 |
| 52W Low | 30.08 |
| 52W Pos | 95.1% |
| From High | −3.35% |
| From Low | +207.08% |
| Max DD 1Y | −48.03% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +3.23% |
| SMA 50 | +8.19% |
| SMA 200 | +62.65% |
| RSI (14) | 59.0 |
| Vol 30D | 49.2% |
| Vol 90D | 49.1% |
| 1Y Range | 30–96 |
| Daily bars | 324 |
| Perf Week | +5.75% |
| Perf Month | +15.35% |
| Perf Quarter | +45.19% |
| Perf Half Y | +100.20% |
| Perf Year | +64.92% |
| Perf YTD | +102.74% |
| Prev Day | +0.00% |
| Clavix | C+ |
| Debt / Eq | 0.00 |
| Curr Ratio | 1.47 |
| Int Cover | — |
| FCF Margin | 41.5% |
| Rev Growth | +53.0% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 44 / 47 |
Clavix risk grade
regraded every trading dayHNGE grades C+, 62 of 100. Steadiest on Sector Resilience (77), most exposed on Macro Resilience (39, fragile). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 44 of 47 in Health Care by Clavix score.
How rough the ride is
| HNGE | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.58 | 0.82 |
| Volatilityannualized | 39.6% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −48.0% | — |
| Typical daily movemedian absolute daily change | 1.76% | — |
| Days beyond ±3%of the last 252 sessions | 7128% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HNGE | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.58 | 0.82 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HNGE | |
|---|---|
| 1 week | +5.7% |
| 1 month | +15.3% |
| Year to date | +102.7% |
| 1 year | +64.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HNGE | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 21 Jul |
| Average score0 most bearish, 100 most bullish | 69 |
| Bullish · bearisharticles above 60 · below 40 | 23 · 2 |
| Directionarticles whose tone is improving vs worsening | 23 ↑ 2 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| HNGE | |
|---|---|
| Revenue growthyear over year | +53.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | HNGE | Sector spread | Median |
|---|---|---|---|
| Beta | 1.58 | 0.82 | |
| Volatility | 39.6% | 20.4% | |
| P/E | 67.15 | 26.45 | |
| Debt / equity | 0.00 | 0.71 | |
| Current ratio | 1.47 | 1.58 | |
| FCF margin | 41.5% | 8.7% |
Recent news
most recent scored articles · the chip is the article’s score · click to openA Hinge Health director, Kristina Leslie, sold 1,200 shares for a total of $105,876, which trimmed her direct stake in the company by 4% while leaving her with a position worth several million dollars. The filing covered only shares she held directly, with no indirect holdings reported.
Hinge Health (HNGE) bought Cylinder Health, a virtual digestive care company, for $105 million in cash, gaining roughly 100 enterprise clients, about two million covered lives, and integrations with two of the three largest pharmacy benefit managers.
Hinge Health raised its full-year 2026 revenue guidance to $856-860 million, well above the $822 million analysts had expected, after Q2 2026 revenue jumped 53% year-over-year to $213 million with operating profit, excluding one-off costs, doubling to $62 million. The company also agreed to buy virtual gastrointestinal care provider Cylinder Health for $105 million in cash and added $300 million to its share buyback program. Two analysts raised their price targets following the results.
Hinge Health raised its full-year 2026 revenue guidance to between $856 million and $860 million, well above the $822 million analysts had expected. The company reported Q2 2026 revenue of $213 million, up 53% from a year earlier, and operating profit (excluding one-off costs) of $62 million, more than double the prior year.
Hinge Health's stock rose 95% after its initial public offering on May 22, 2025, which priced shares at $32. The company sells an app-based, AI-powered program for managing pain, and says demand from clients is rising.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| HIMS | Hims & Hers Health Inc | D- | $6.47B | 50.37 | 2.54 | Compare |
| UHS | Universal Health Services Inc | A- | $10.00B | 6.55 | 1.13 | Compare |
| HSIC | Henry Schein Inc | A- | $10.01B | 24.84 | 0.87 | Compare |
| PODD | Insulet Corp | C | $10.23B | 27.25 | 1.08 | Compare |
| GKOS | Glaukos Corp | B- | $10.47B | — | 0.73 | Compare |
| MOH | Molina Healthcare Inc | B | $10.48B | 22.21 | 0.74 | Compare |
| GMED | Globus Medical Inc | B | $10.51B | 19.63 | 0.99 | Compare |
| ALGN | Align Technology Inc | B- | $11.27B | 27.25 | 1.73 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.